Phoenix Group and Migdal have supplied capital for Arkin Bio-Ventures II, which investment firm Arkin Holdings will use to invest in 10 to 12 drug developers.

Gree's corporate venturing arm has closed its third fund having raised more than $100m despite failing to reach its initial target.

Cash Capital portfolio company VIPioneers has closed on series A2 funding in the run-up to mass-production of its autonomous coalmine transport system.

Corporate venturing units BCH Ventures and Singha Ventures are among the limited partners for Creative Ventures' second fund, which is over halfway to its $50m target.

Novartis and Harel are among the investors set to exit the cancer therapy developer, which also counts Bristol-Myers Squibb as a shareholder.

AIA, Tencent, Fosun, NWS Holdings and Tyan Home could exit the medical booking platform in an initial public offering valuing it at more than $10bn.

Meituan Dianping led a round for the agricultural distribution services provider that also featured existing backer Hidden Hill.

Nxrobo participated in a $14.4m round for satellite services provider MinoSpace, whose early investors include Yongxin and China Aerospace Science and Industry Corporation.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

ABB Technology Ventures and NEC took part in a $60m series B round that will support the AI processor developer’s global expansion efforts.